University of Genova
Genoa, 16132, Italy
NCT Number: NCT03981159
The objective of this study was to examine the effects of exercise training on physical function and biochemical markers in elderly Alzheimer's disease patients.
Looking for future studies?
Notify Me80 year–90 year
All sexes
Interventional
Not applicable
Genoa, 16132, Italy
Alzheimer's disease is a neurodegenerative disease characterized by progressive and irreversible degeneration of nerve cells. The loss of these cells leads to the continuous decline in muscle function with alterations in biochemical and haematological parameters. The objective of this study was to examine the effects of exercise training on physical function and biochemical markers in elderly Alzheimer's disease patients.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Physical training for three months, twice per week (60 minutes per session).
Time frame: Approximately 10-15 minutes
The 3-likert test assesses balance and gait abilities with an individual sitting in an armless chair, rising up, staying standing, turning 360° and then sitting back down. Gait is scored over 12 and balance is scored over 16, totalling 28 points.
Time frame: Approximately 20 minutes
The 14-item 5-likert (from 0 to 4) scale objectively determines a patient's balance ability during a series of predetermined tasks. Scores of each item are summed up: the total score ranges from 0 to 56. The lowest the score the lowest is the level of function, the highest the score the highest is the level of function.
Time frame: 6 minutes
This test is a sub-maximal exercise used to evaluate aerobic capacity and endurance.
Time frame: Approximately 14 seconds
The test measures abilities of a patient initially in a seated position The patient is then asked to stand up up, walk 3 meters, turn around, walk back to the chair and sit down.
Time frame: Approximately 1 minute
This test is a dual-task test, consisting in walking while reciting the alphabet or alternate letters of the alphabet.
Time frame: Approximately 10-15 minutes
Assessed with routine blood/biochemical assays
Time frame: Approximately 10-15 minutes
Assessed with routine blood/biochemical assays
Time frame: Approximately 10-15 minutes
Assessed with routine blood/biochemical assays
Time frame: Approximately 10-15 minutes
Assessed with routine blood/biochemical assays
Time frame: Approximately 10-15 minutes
Assessed with routine blood/biochemical assays
Time frame: Approximately 10-15 minutes
Assessed with routine blood/biochemical assays
Time frame: Approximately 10-15 minutes
Assessed with routine blood/biochemical assays
Time frame: Approximately 10-15 minutes
Assessed with routine blood/biochemical assays
Time frame: Approximately 10-15 minutes
Assessed with routine blood/biochemical assays
Time frame: Approximately 10-15 minutes
Assessed with routine blood/biochemical assays
Time frame: Approximately 10-15 minutes
Assessed with routine blood/biochemical assays
Time frame: Approximately 10-15 minutes
Assessed with routine blood/biochemical assays
Time frame: Approximately 10-15 minutes
Assessed with routine blood/biochemical assays
Time frame: Approximately 10-15 minutes
Assessed with routine blood/biochemical assays
Time frame: Approximately 10-15 minutes
Assessed with routine blood/biochemical assays
Time frame: Approximately 10-15 minutes
Assessed with routine blood/biochemical assays
Time frame: Approximately 10-15 minutes
Assessed with routine blood/biochemical assays
University of Genova
Other
Effect of Exercise Training on Biochemical and Gait/Balance Parameters in Alzheimer's Patients
Acronym: ExCiTE-A
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04865172
Alzheimer Disease, Brain Diseases
Paris, France
View Trial DetailsNCT06347172
Alzheimer Disease, Brain Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT04992195
Alzheimer Disease, Arterial Thromboembolism
Hong Kong
View Trial DetailsNCT05529706
Alzheimer Disease, Brain Diseases
San Francisco, California, United States
View Trial Details